0.10Open0.10Pre Close105 Volume3.73K Open Interest0.50Strike Price935.00Turnover258.42%IV49.63%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type0.5038Delta1.4890Gamma5.35Leverage Ratio-0.0022Theta0.0001Rho2.70Eff Leverage0.0004Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet